申请人:Beijing Peking University WBL Biotech Co., Ltd.
公开号:US10093695B2
公开(公告)日:2018-10-09
The present disclosure discloses a sterol derivative, a preparation method therefor and a use thereof. The sterol derivative includes a sterol compound with Structural Formula (I) or a pharmaceutically acceptable salt thereof, or an extract containing the sterol compound, or a composition containing the sterol compound, wherein Structural Formula (I) is as follows:
where R1 is —OH, ═O, H or C1-C3 alkyl; R2 is —OH, H or C1-C3 alkyl; R3 is —OH, ═O, H or C1-C3 alkyl; R4 is —OH, H or C1-C3 alkyl, and at least one of R1, R2, R3 and R4 is —OH. The compound with Structural Formula (I) can be used for preparing a drug having inhibitory effect on 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase activity and the prepared drug can effectively inhibit the HMG-CoA reductase activity or be used for preparing an anti-cancer drug.
本公开披露了一种甾醇衍生物、其制备方法及其用途。甾醇衍生物包括结构式(I)的甾醇化合物或其药学上可接受的盐、或含有该甾醇化合物的提取物、或含有该甾醇化合物的组合物,其中结构式(I)如下:
其中R1为-OH、═O、H或C1-C3烷基;R2为-OH、H或C1-C3烷基;R3为-OH、═O、H或C1-C3烷基;R4为-OH、H或C1-C3烷基,且R1、R2、R3和R4中至少有一个为-OH。结构式(I)的化合物可用于制备对 3-羟基-3-甲基戊二酰辅酶 A(HMG-CoA)还原酶活性有抑制作用的药物,制备的药物可有效抑制 HMG-CoA 还原酶活性或用于制备抗癌药物。